Tsunetsugu-Yokota Y, Honda M, Tokunaga T
Department of Cellular Immunology, National Institute of Health, Tokyo, Japan.
Hybridoma. 1989 Aug;8(4):391-400. doi: 10.1089/hyb.1989.8.391.
A Human OKT8-positive T cell hybridoma was established by using concanavalin A (ConA)-activated peripheral blood mononuclear cells (PBMC) fused with CEM-AGR cells. A culture supernatant of the established T cell hybridoma HI4.2D6 inhibited the mitogen induced proliferation of peripheral blood mononuclear cells (PBMC). It inhibited IL-1-, IL-2, or IL-3-dependent proliferation of each factor-dependent mouse cell lines. While the inhibitory activity of IL-1-induced proliferation was stable, that of IL-2- and IL-3-induced proliferation was abrogated within a week at 4 degrees C. Inhibition of IL-2-dependent growth was also observed using human IL-2-dependent cells, but the growth of other factor-independent human hematopoietic cell lines was not affected at all. By gel filtration, the activity inhibiting IL-2- or IL-3-dependent proliferation was found in the fractions with approximate molecular weight of 18,000 and 100,000.
通过使用伴刀豆球蛋白A(ConA)激活的外周血单个核细胞(PBMC)与CEM-AGR细胞融合,建立了一株人OKT8阳性T细胞杂交瘤。所建立的T细胞杂交瘤HI4.2D6的培养上清液抑制了丝裂原诱导的外周血单个核细胞(PBMC)增殖。它抑制了每种因子依赖性小鼠细胞系的IL-1、IL-2或IL-3依赖性增殖。虽然IL-1诱导增殖的抑制活性稳定,但IL-2和IL-3诱导增殖的抑制活性在4℃下一周内消失。使用人IL-2依赖性细胞也观察到对IL-2依赖性生长的抑制,但其他因子非依赖性人造血细胞系的生长完全不受影响。通过凝胶过滤,在分子量约为18,000和100,000的级分中发现了抑制IL-2或IL-3依赖性增殖的活性。